Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 2/20 | 0.49 |
| ▸ | DGKA | P23743 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | POLA1 | P09884 | 1/20 | 0.44 |
| ▸ | PAM | P19021 | 2/20 | 0.44 |
| ▸ | CES2 | O00748 | 4/20 | 0.43 |
| ▸ | CES1 | P23141 | 4/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | CNR1 | P21554 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.41 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.41 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27700699 | 0.98 | DGKA (0.52) | CNR2DGKATSHRLMNAHSP90AA1 | |
| SCHEMBL27482958 | 0.98 | DGKA (0.52) | CNR2DGKATSHRLMNAHSP90AA1 | |
| SCHEMBL11599334 | 0.94 | CNR2 (0.42) | CNR2DGKATSHRLMNAHSP90AA1 | |
| SCHEMBL10699569 | 0.87 | LMNA (0.41) | CNR2DGKATSHRLMNAHSP90AA1 | |
| SCHEMBL28148318 | 0.85 | — | — | |
| SCHEMBL28165411 | 0.85 | TSHR (0.46) | CNR2TSHRLMNACNR1 | |
| SCHEMBL7181018 | 0.81 | TSHR (0.56) | CNR2DGKATSHRLMNAHSP90AA1 | |
| SCHEMBL27358889 | 0.80 | ALDH1A1 (0.40) | CNR2DGKATSHRLMNAMAPT | |
| SCHEMBL4877636 | 0.77 | PAOX (0.40) | TSHRDNM1 | |
| SCHEMBL3630253 | 0.77 | DGKA (0.54) | CNR2DGKATSHRLMNAHSP90AA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109651021-A | A kind of full source high-efficiency sustained-release Eco-fertilizer of sweet potato suitable for plains region | 山东农大腐植酸高效利用工程技术研发有限公司 | 2019-04-19 | — | — | CN | claimed |
| CN-108101614-A | Coating controlled-release fertilizer and preparation method thereof | 深圳市芭田生态工程股份有限公司 | 2018-06-01 | — | — | CN | claimed |
| CN-108083891-A | A kind of slow release long-acting compound fertilizer and preparation method thereof | 四川汇农新创生物科技有限公司 | 2018-05-29 | — | — | CN | claimed |
| CN-106278765-A | A kind of organic soil conditioner | 张鸿 | 2017-01-04 | — | — | CN | claimed |
| CN-105110993-A | Controlled-release high-nitrogen liquid fertilizer with effect of improving nitrogen use efficiency and preparation method of controlled-release high-nitrogen liquid fertilizer | ANHUI FEITIAN AGRICULTURAL BIOTECHNOLOGY CO LTD | 2015-12-02 | — | — | CN | claimed |
| CN-104496706-A | Ammonium-aldehyde dually-controlled compound fertilizer and preparation method thereof | SHANDONG SHIBEIMEI FERTILIZER DEV CO LTD | 2015-04-08 | — | — | CN | claimed |
| CN-1901895-A | Methods of treating cancer with hdac inhibitors | ATON PHARMA INC (US) | 2007-01-24 | — | — | CN | claimed |
| CN-1843508-A | Pharmaceutical composition for treating gastrointestinal distress | ANCHENG PHARMACEUTICAL TECHNOL (CN) | 2006-10-11 | — | — | CN | claimed |
| CN-1728991-A | Combination therapy for the treatment of cancer | SLOAN KETTERING INST CANCER (US) | 2006-02-01 | — | — | CN | claimed |
| CN-109651021-B | Sweet potato all-source efficient slow-release ecological fertilizer suitable for plain areas | 山东农大肥业科技有限公司 | 2022-01-18 | — | — | CN | disclosed |
| US-11124522-B2 | Chemosensor and a method of detecting palladium ions | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2021-09-21 | — | — | US | disclosed |
| US-20200392148-A1 | CHEMOSENSOR AND A METHOD OF DETECTING PALLADIUM IONS | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2020-12-17 | — | — | US | disclosed |
| CN-109715198-A | For treating the material and method of hemoglobinopathy | 克里斯珀医疗股份公司 | 2019-05-03 | — | — | CN | disclosed |
| CN-109651021-A | A kind of full source high-efficiency sustained-release Eco-fertilizer of sweet potato suitable for plains region | 山东农大腐植酸高效利用工程技术研发有限公司 | 2019-04-19 | — | — | CN | disclosed |
| CN-1843508-A | Pharmaceutical composition for treating gastrointestinal distress | ANCHENG PHARMACEUTICAL TECHNOL (CN) | 2006-10-11 | — | — | CN | disclosed |
| CN-1728991-A | Combination therapy for the treatment of cancer | SLOAN KETTERING INST CANCER (US) | 2006-02-01 | — | — | CN | disclosed |
| CN-1720034-A | Method for inducing terminal differentiation | ATON PHARMA INC (US) | 2006-01-11 | — | — | CN | disclosed |
| US-20050153128-A1 | Product packaging including digital data | SELINFREUND RICHARD H (US) | 2005-07-14 | — | — | US | disclosed |
| CN-1085912-A | Peptide compounds | HAFSLUND NYCOMED AS (NO) | 1994-04-27 | — | — | CN | disclosed |
| US-5237046-A | Reacting alkali metal sulfides with acids to form salts | BAYER AKTIENGESELLSCHAFT (DE) | 1993-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11124522-B2 | Chemosensor and a method of detecting palladium ions | DDT, PDCD1, PDCD10 | CNR2 1042/4885DGKA 1033/4885TSHR 3174/4885 |
| US-20200392148-A1 | CHEMOSENSOR AND A METHOD OF DETECTING PALLADIUM IONS | DDT, PDCD1, PDCD10 | CNR2 1042/4885DGKA 1033/4885TSHR 3174/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.